Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Healthy Adult Immune Response”

291 trials

Showing 20 of 291 results

Early research (Phase 1)Ended earlyNCT06544642
What this trial is testing

Evaluate the Effects of ASP5502 in Healthy Adults and Adults With Primary Sjögren's Syndrome

Who this might be right for
Healthy VolunteersSjögren's Syndrome
Astellas Pharma Global Development, Inc. 116
Testing effectiveness (Phase 2)Study completedNCT02956837
What this trial is testing

Rank Different Dosages of Antigen of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3003891A), Based on Their Immune Response and Safety, When Administered to Healthy Adult Women

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 406
Early research (Phase 1)Study completedNCT06476275
What this trial is testing

Single Dose Texas 2017 (H3N2) Challenge Study

Who this might be right for
Influenza Viral Infections
Duke University 33
Early research (Phase 1)Study completedNCT04851977
What this trial is testing

A First in Human Study to Evaluate the Safety and Immune Response to a Vaccine for the Treatment of a Respiratory Virus, When Administered Into the Arm in Healthy Adult Participants

Who this might be right for
Respiratory Syncytial Virus Infections
Advaccine (Suzhou) Biopharmaceuticals Co., Ltd. 60
Early research (Phase 1)Study completedNCT05968989
What this trial is testing

Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Mosaic Hexavalent Influenza Vaccine VRC-FLUMOS0116-00-VP (FluMos-v2) in Healthy Adults

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 30
Early research (Phase 1)Study completedNCT00083330
What this trial is testing

Safety and Immunogenicity of an HIV Vaccine in Normal Adult Volunteers

Who this might be right for
HealthyHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 36
Not applicableStudy completedNCT01771367
What this trial is testing

Training Study to Characterize Biomarkers to Flu Vaccines

Who this might be right for
Healthy
University of Surrey 49
Early research (Phase 1)Study completedNCT02057263
What this trial is testing

The Effect of Alendronate on the Immune Response to Hepatitis B Vaccine in Healthy Adults

Who this might be right for
Hepatitis B
Massachusetts General Hospital 28
Early research (Phase 1)Study completedNCT00089908
What this trial is testing

Safety of and Immune Response to a Dengue Virus Vaccine (rDEN1delta30) in Healthy Adults

Who this might be right for
Dengue Fever
National Institute of Allergy and Infectious Diseases (NIAID) 28
Early research (Phase 1)Study completedNCT05972993
What this trial is testing

A Safety and Immune Response Study to Evaluate Varying Doses of an mRNA Vaccine Against Coronavirus Disease 2019 (COVID-19) in Healthy Adults

Who this might be right for
COVID-19
GlaxoSmithKline 114
Early research (Phase 1)Study completedNCT04826094
What this trial is testing

Assess the Safety and Immune Response to Env-C DNA and Protein Vaccines in Kenya

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 143
Early research (Phase 1)Study completedNCT01379430
What this trial is testing

Safety and Immunogenicity of AdCh63 ME-TRAP and MVA ME-TRAP Vaccines in Malaria Endemic Areas

Who this might be right for
Malaria
University of Oxford 30
Early research (Phase 1)Study completedNCT00801697
What this trial is testing

Safety and Immune Response to Preventive HIV Immunization With Adenovirus Serotype 5 or 35 Vector

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 192
Early research (Phase 1)Study completedNCT06585891
What this trial is testing

Study of a Human Bispecific Antibody VRC-HIVMAB0121-00-AB (CAP256J3LS) Administered Intravenously or Subcutaneously to Healthy Adults

Who this might be right for
HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 24
Early research (Phase 1)Study completedNCT01438606
What this trial is testing

Evaluating the Safety of and Immune Response to the VSV-Indiana HIV Vaccine in Healthy, HIV-Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 60
Post-approval studies (Phase 4)UnknownNCT02514018
What this trial is testing

Pilot Study to Describe Immune Responses of Healthy Women Following Immunization With Varicella Zoster Virus Vaccine

Who this might be right for
Healthy
University of Toronto 45
Early research (Phase 1)Study completedNCT02375256
What this trial is testing

A Leukapheresis Study for Immune Responses in Healthy US Adults Who Receive BCG Vaccination Followed by Boosting With AERAS-402

Who this might be right for
Tuberculosis
Aeras 11
Early research (Phase 1)Study completedNCT02408913
What this trial is testing

VRC 208: Dose, Safety and Immunogenicity of a Recombinant Modified Vaccinia Virus Ankara Ebola Vaccine, VRC-EBOMVA079-00-VP (MVA-EbolaZ), Administered Alone or as a Boost to cAd3-Ebola Vaccines in Healthy Adults

Who this might be right for
Healthy Adult Immune Responses to Vaccine
National Institute of Allergy and Infectious Diseases (NIAID) 140
Large-scale testing (Phase 3)Study completedNCT02414412
What this trial is testing

Immunity Improvement Effect of Ulmus Macrocarpa Water Extract in Adults

Who this might be right for
Healthy
Pusan National University Hospital 58
Early research (Phase 1)WithdrawnNCT01970449
What this trial is testing

Evaluating the Safety and Immune Response to Three Different Prime-Boost HIV Vaccine Regimens in Healthy, HIV-Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation